Profil bibliographique

Cristina Encinas

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

86Publications signalées

1606Citations signalées

1Affiliations récentes

Institutions déclarées

Hospital General Universitario Gregorio Marañón

Domaines associés

Multiple Myeloma Research and TreatmentsProtein Degradation and InhibitorsCancer Treatment and PharmacologyPeptidase Inhibition and AnalysisAnalytical Chemistry and Sensors

Publications récentes

Accès ouvert 2026 letterOpenAlex

A Response to: Letter to the Editor Regarding “Cost-Effectiveness of Elranatamab Versus Current Therapies for the Management of Patients with Triple-Class Exposed, Relapsed and Refractory Multiple Myeloma, Including Other Bispecific and Physician’s Choice of Treatment in Spain”

Virginia Lozano, Julia Llinares, Patrick Halavacek, Olivia Ashman et autres

0 citationsOncology and Therapy

Accès ouvert 2026 articleOpenAlex

Immune biomarkers of increased infection risk in multiple myeloma

Aintzane Zabaleta, Luis‐Esteban Tamariz‐Amador, Ioannis V. Kostopoulos, Romanos Sklavenitis Pistofidis et autres

4 citationsBlood

2025 conference-abstractOpenAlex

Iberdomide plus daratumumab and dexamethasone (IberDd) in patients with newly diagnosed multiple myeloma by renal function: A subgroup analysis of the CC-220-MM-001 trial

Anna Sureda Balarí, Abdullah Khan, Albert Oriol, Faiz Anwer et autres

0 citationsBlood

Accès ouvert 2025 conference-abstractOpenAlex

Immune biomarkers of increased risk of infection in multiple myeloma (MM)

Aintzane Zabaleta, Luis‐Esteban Tamariz‐Amador, Ioannis V. Kostopoulos, Romanos Sklavenitis‐Pistofidis et autres

0 citationsBlood

Accès ouvert 2025 articleOpenAlex

Molecular detection of carbapenemases in critical microorganisms since the onset of the COVID-19 pandemic in Peru

Maritza Mayta-Barrios, Juan Ramírez-Illescas, Juan Pacori, Joshi Acosta et autres

2 citationsJAC-Antimicrobial Resistance

2025 articleOpenAlex

Final Analysis of the GEM-BELA-VRd Phase II Trial: Belantamab Mafodotin Plus VRd in Newly Diagnosed Transplant-Eligible Myeloma After 2 Years of Maintenance with Belantamab and Lenalidomide

Verónica González‐Calle, Noemí Puig, Enrique M. Ocio, Javier de la Rubia et autres

1 citationClinical Lymphoma Myeloma & Leukemia

2025 articleOpenAlex

Factors Increasing the Risk of Infection in Patients With Multiple Myeloma: From Biology to Prevention

Cristina Encinas, María Jesús Blanchard, Rafael Alonso, José‐Ángel Hernández‐Rivas et autres

2 citationsClinical Lymphoma Myeloma & Leukemia

Accès ouvert 2025 articleOpenAlex

Cost-Effectiveness of Elranatamab Versus Current Therapies for the Management of Patients with Triple-Class Exposed, Relapsed and Refractory Multiple Myeloma, Including Other Bispecific and Physician’s Choice of Treatment in Spain

Cristina Encinas, Virginia Lozano, Patrick Hlavacek, Julia Llinares et autres

8 citationsOncology and Therapy

Accès ouvert 2024 conference-abstractOpenAlex

Survival Improvement of Transplant Eligible Patients with Newly Diagnosed Multiple Myeloma in Two Consecutive Randomized Phase III Trials: Long-Term Follow up of GEM05 and GEM12 Trials

Laura Rosiñol Dachs, Albert Oriol, María‐Jesús Blanchard, Javier de la Rubia et autres

0 citationsBlood

2024 articleOpenAlex

Immunoparesis recovery in newly diagnosed transplant ineligible multiple myeloma patients, an independent prognostic factor that complements minimal residual disease

Sunil Lakhwani, María‐Victoria Mateos, Joaquín Martínez‐López, Bruno Paiva et autres

0 citationsAnnals of Hematology

2024 articleOpenAlex

Minimally Invasive Assessment of Peripheral Residual Disease During Maintenance or Observation in Transplant-Eligible Patients With Multiple Myeloma

Marta Lasa, Laura Notarfranchi, Cristina Agulló, Carmen González et autres

16 citationsJournal of Clinical Oncology

Accès ouvert 2024 preprintOpenAlex

Immunoparesis Recovery in Newly Diagnosed Transplant Ineligible Multiple Myeloma Patients, an Independent Prognostic Factor That Complements Minimal Residual Disease

Sunil Lakhwani, María‐Victoria Mateos, Joaquín Martínez‐López, Bruno Paiva et autres

0 citationsResearch Square

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.